What happens if millions of patients lose significant weight and need less blood pressure medication or can come off certain medications
Appetite Regulation and Satiety Research Researchers apply Cagrilintide in appetite regulation studies extensively
Understanding these side effects is crucial to ensure the safe and effective use of semaglutide in this patient population
Here is who benefits most: Good fit if you: Qualify for GLP-1 medication (BMI 30+ or BMI 27+ with a weight-related condition) Want behavioral coaching alongside medication, not just a prescription Prefer a structured program with lessons, food logging, and community support Have tried medication alone and struggled with side effects or regain Want compounded medication shipped to your door (avoiding pharmacy visits) Not a good fit if you: Want the cheapest way to get a GLP-1 prescription (Ro and similar services are less expensive for medication-only access) Already have strong nutrition habits and just need the drug Live in Alabama, Louisiana, Mississippi, or Virginia (some programs unavailable) Have a history of medullary thyroid cancer, multiple endocrine neoplasia 2, or active gastrointestinal conditions like gastroparesis Want brand-name medication but do not have insurance to cover it (the out-of-pocket drug cost makes it very expensive) How Noom Med Compares to Alternatives The GLP-1 telehealth space has gotten crowded
Although some patients dislike needles, others dont seem to mind the weekly injections, obesity experts said
The near exclusive focus on "my drug allows more weight loss than the one of the competitors" is toxic and contribute to reinforce stigma
